The surprise voiced in this article is suprising. Now that the NY Times has told me about it, this idea of buying the one company that makes a particular generic drug and then raising the price ridiculously high makes a lot of sense. I wonder if they thought they'd lower the price as sales dropped and were themselves surprised when this didn't happen. I gotta agree with jug5: "Breaking News: America doesn't understan…
This company and this example of abusive trading will single-handedly drive further regulation of the pharmaceutical industry.